SCHEMBL7083798

SCHEMBL7083798

CC(=O)Nc1cc(NC(=O)c2ccccc2-c2ccccc2C(F)(F)F)ccc1OCCc1ccccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 4/20 0.44
KCNK3 O14649 1/20 0.42
KCNK9 Q9NPC2 1/20 0.42
SMO Q99835 2/20 0.42
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
HTR2B P41595 1/20 0.41
RXFP1 Q9HBX9 2/20 0.41
PTPRC P08575 1/20 0.41
KDM4E B2RXH2 2/20 0.41
HPGD P15428 2/20 0.41
S1PR1 P21453 1/20 0.41
LMNA P02545 2/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
PAX8 Q06710 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6789334 0.88 SMO (0.56) SMORXFP1KDM4EHPGDSMN1; SMN2
SCHEMBL7083795 0.86 HTR2A (0.42) GRM4SMOHTR2AHTR2CHTR2B
SCHEMBL6504077 0.82 SMO (0.48) SMORXFP1KDM4EHPGDHTT
SCHEMBL6795346 0.76 SMO (0.59) SMOSMN1; SMN2
SCHEMBL7085677 0.76 LMNA (0.45) GRM4SMOPTPRCLMNARAB9A
SCHEMBL6789743 0.75 SMO (0.58) SMOSMN1; SMN2
SCHEMBL7083793 0.73 HTT (0.39) SMOKDM4EHPGDLMNAHTT
SCHEMBL6792614 0.73 SMO (0.55) SMOLMNAMAPTSMN1; SMN2
SCHEMBL6795032 0.72 SMO (0.54) SMORXFP1
SCHEMBL6492227 0.70 SMO (0.49) SMOSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-16 EP disclosed
WO-2002028835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-04-11 WO disclosed